A functional MRI study of motor dysfunction in Friedreich's ataxia

Grants

Funding Acknowledgements

Friedreich Ataxia Research Association (Australasia), Friedreich Ataxia Research Alliance (USA) and Murdoch Children's Research Institute. H.A. has received a Melbourne International Fee Remission Scholarship and a Melbourne International Research Scholarship. M.B.D. is a NHMRC Practitioner fellow. G.F.E. is an NHMRC Research Fellow.We thank the participants for taking part in this study. This study was supported by funding from the Friedreich Ataxia Research Association (Australasia), Friedreich Ataxia Research Alliance (USA) and Murdoch Childrens Research Institute. H.A. received a Melbourne International Fee Remission Scholarship and a Melbourne International Research Scholarship. M.B.D. is a NHMRC Practitioner Fellow. G.F.E. is an NHMRC Research Fellow.Dr. Hamed Akhlaghi received a Melbourne International Fee Remission Scholarship and a Melbourne International Research Scholarship. Louise Corben reports no disclosures. Associate Professor Nellie Georgiou-Karistianis reports no disclosures. Emeritus Professor John Bradshaw reports no disclosures. Professor Elsdon Storey has received honoraria (payable to his institution) from Pfizer for lecturing on non-drug related issues at an education course. He is a co-investigator on an NIH trial for which Merck is providing active drug (aspirin and placebo). Professor Martin B. Delatycki is Associate Editor for BMC Neurology, he receives grants from NHMRC, Friedreich Ataxia Research Alliance, Friedreich Ataxia Research Association, and he is on the Pfizer Australia Neuroscience Grant Panel. Professor Gary Egan reports no disclosures.